TCL Archive NCS Group Asks DRG Adjustments For Institutions With Peer reviewed Components, 25 Protocol Patients July 1, 1983
TCL Archive VEGF Inhibitor Slows Thyroid Cancer Progression In Some Patients, Study Finds July 25, 2008
TCL Archive Genentech Move Nixes Hospital Discounts: Avastin, Herceptin, Rituxan Now Sold Under Tighter Control by Drug Maker October 3, 2014